The risk of colorectal cancer in patients with inflammatory bowel diseases in Finland: A follow-up of 20years

Journal of Crohn's and Colitis

Volumn 7, Issue 11, 2013, Pages

  Manninen, Pia ^a,b   Karvonen, Anna Liisa ^a   Huhtala, Heini ^b   Aitola, Petri ^a   Hyöty, Marja ^a   Nieminen, Ilona ^a   Hemminki, Heini ^b   Collin, Pekka ^a,b  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

Colorectal cancer; Crohn's disease; Inflammatory bowel diseases; Ulcerative colitis

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER LOCALIZATION; CANCER PREVENTION; CANCER REGISTRY; CANCER RISK; CANCER SCREENING; CECUM CANCER; CHILD; COLON RESECTION; COLONOSCOPY; COLORECTAL CANCER; CROHN DISEASE; DISEASE SEVERITY; ENTERITIS; FAMILY HISTORY; FEMALE; FIRST DEGREE RELATIVE; FOLLOW UP; GASTROINTESTINAL DYSPLASIA; GASTROINTESTINAL ENDOSCOPY; GENDER; HUMAN; INFLAMMATION; INTESTINE POLYP; MAJOR CLINICAL STUDY; MALE; POLYPOSIS; POPULATION RESEARCH; PRESCHOOL CHILD; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROCTOCOLECTOMY; RECTUM CANCER; SCANDINAVIA; SCHOOL CHILD; SIGMOID; STANDARDIZED INCIDENCE RATIO; TRANSVERSE COLON; ULCERATIVE COLITIS;

COLORECTAL CANCER; CROHN'S DISEASE; INFLAMMATORY BOWEL DISEASES; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CELL TRANSFORMATION, NEOPLASTIC; COLITIS, ULCERATIVE; COLONOSCOPY; COLORECTAL NEOPLASMS; COMORBIDITY; CONFIDENCE INTERVALS; CROHN DISEASE; EARLY DETECTION OF CANCER; FEMALE; FINLAND; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; POISSON DISTRIBUTION; REGISTRIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SURVIVAL ANALYSIS; TIME FACTORS; YOUNG ADULT;

EID: 84884812431     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2013.04.003     Document Type: Article

References (30)

1. Crohn B.B.M.D., Rosenberg H.M.D. The sigmoidoscopic picture of chronic ulcerative colitis (non-specific). Am J Med Sci 1925, 170:220-227.
2. Bernstein C.N., Blanchard J.F., Kliewer E., Wajda A. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 2001, 91:854-862.
3. Eaden J.A., Abrams K.R., Mayberry J.F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001, 48:526-535.
4. Gillen C.D., Andrews H.A., Prior P., Allan R.N. Crohn's disease and colorectal cancer. Gut 1994, 35:651-655.
5. Greenstein A.J., Sachar D.B., Smith H., Janowitz H.D., Aufses A.H. A comparison of cancer risk in Crohn's disease and ulcerative colitis. Cancer 1981, 48:2742-2745.
6. Jess T., Winther K.V., Munkholm P., Langholz E., Binder V. Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen county, Denmark. Aliment Pharmacol Ther 2004, 19:287-293.
7. Karlen P., Lofberg R., Brostrom O., Leijonmarck C.E., Hellers G., Persson P.G. Increased risk of cancer in ulcerative colitis: a population-based cohort study. Am J Gastroenterol 1999, 94:1047-1052.
8. Rutter M.D., Saunders B.P., Wilkinson K.H., Rumbles S., Schofield G., Kamm M.A., et al. Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. Gastroenterology 2006, 130:1030-1038.
9. Jess T., Rungoe C., Peyrin-Biroulet L. Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies. Clin Gastroenterol Hepatol 2012, 10:639-645.
10. Baars J.E., Looman C.W., Steyerberg E.W., Beukers R., Tan A.C., Weusten B.L., et al. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study. Am J Gastroenterol 2011, 106:319-328.
11. Ekbom A., Helmick C., Zack M., Adami H.O. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990, 336:357-359.
12. Gupta R.B., Harpaz N., Itzkowitz S., Hossain S., Matula S., Kornbluth A., et al. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007, 133:1099-1105.
13. Jess T., Loftus E.V., Velayos F.S., Winther K.V., Tremaine W.J., Zinsmeister A.R., et al. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota. Am J Gastroenterol 2007, 102:829-836.
14. Hendriksen C., Kreiner S., Binder V. Long term prognosis in ulcerative colitis-based on results from a regional patient group from the county of Copenhagen. Gut 1985, 26:158-163.
15. Kewenter J.M.D., Ahlman H.M.D., Hulten L.M.D. Cancer risk in extensive ulcerative colitis. Ann Surg 1978, 188:824-828.
16. Jess T., Simonsen J., Jorgensen K.T., Pedersen B.V., Nielsen N.M., Frisch M. Decreasing risk of colorectal cancer in patients with inflammatory bowel disease over 30years. Gastroenterology 2012, 143. [375,81.e1].
17. Eaden J.A., Mayberry J.F. British Society for G, Association of Coloproctology for Great Britain and, Ireland. Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 2002, 51:10-12.
18. Cairns S.R., Scholefield J.H., Steele R.J., Dunlop M.G., Thomas H.J., Evans G.D., et al. Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002). Gut 2010, 59:666-689.
19. Farraye F.A., Odze R.D., Eaden J., Itzkowitz S.H. AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010, 138:746. [Feb-774].
20. Farraye F.A., Odze R.D., Eaden J., Itzkowitz S.H., McCabe R.P., Dassopoulos T., et al. AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology 2010, 138:738-745.
21. Van Assche G., Dignass A., Bokemeyer B., Danese S., Gionchetti P., Moser G., et al. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis: special situations. J Crohn's Colitis 2013, 7:1-33.
22. Jones H.W., Grogono J., Hoare A.M. Surveillance in ulcerative colitis: burdens and benefit. Gut 1988, 29:325-331.
23. Fozard J.B., Dixon M.F. Colonoscopic surveillance in ulcerative colitis-dysplasia through the looking glass. Gut 1989, 30:285-292.
24. Manninen P., Karvonen A.L., Huhtala H., Rasmussen M., Collin P. The epidemiology of inflammatory bowel diseases in Finland. Scand J Gastroenterol 2010, 45:1063-1067.
25. Altman D.G., Machin D., Bryant T.N., Gardner M.J. Statistics with confidence 2000, BMJ Books, London. 2nd ed.
26. Bernstein C.N., Eaden J., Steinhart A.H., Munkholm P., Gordon P.H. Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid. Inflamm Bowel Dis 2002, 8:356-361.
27. Jess T., Loftus E.V., Velayos F.S., Harmsen W.S., Zinsmeister A.R., Smyrk T.C., et al. Risk of intestinal cancer in inflammatory bowel disease: a population-based study from Olmsted county, Minnesota. Gastroenterology 2006, 130:1039-1046.
28. Soderlund S., Brandt L., Lapidus A., Karlen P., Brostrom O., Lofberg R., et al. Decreasing time-trends of colorectal cancer in a large cohort of patients with inflammatory bowel disease. Gastroenterology 2009, 136:1561-1567.
29. Winther K.V., Jess T., Langholz E., Munkholm P., Binder V. Long-term risk of cancer in ulcerative colitis: a population-based cohort study from Copenhagen county. Clin Gastroenterol Hepatol 2004, 2:1088-1095.
30. Korhonen P., Malila N., Pukkala E., Teppo L., Albanes D., Virtamo J. The Finnish cancer registry as follow-up source of a large trial cohort-accuracy and delay. Acta Oncol 2002, 41:381-388.